AI Innovation in Clinical Trials

In this episode of the podcast, Dr. David Bearss sits down with Dr. Chris Gibson, Co-Founder and CEO of Recursion.

Dr. Gibson shares his journey from graduate research at the University of Utah to building Recursion into one of the most advanced AI-driven drug discovery companies in the world. They discuss the intersection of biology and machine learning, the future of drug development, and how Recursion is leveraging massive proprietary datasets and the most powerful supercomputer in pharma to reshape the healthcare landscape.

Sponsors

BioHive: ⁠https://www.biohive.com/⁠

Galvan: https://www.galvan.health/

Follow Good Medicine Podcast

Insta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠

TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn:https://www.linkedin.com/company/goodmedicinepodcast/⁠